DISCLOSEDQuarterly
Oaktree Capital Management
Cogent Biosciences Inc · NASDAQ
11,890,000 sh · $14.8M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Cogent Biosciences Inc · NASDAQ
11,890,000 sh · $14.8M
Oaktree Capital Management
Cogent Biosciences Inc · NASDAQ
10,221,000 sh · $12.5M
Oaktree Capital Management
Cogent Biosciences Inc · NASDAQ
7,650,000 sh · $9.0M